Protect Pharmaceutical Corp (PRTT) financial statements (2021 and earlier)

Company profile

Business Address 95 MERRICK WAY, THIRD FLOOR
CORAL GABLES, FL 33143
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
12/31/2011
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments  0111
Cash and cash equivalents  0111
Prepaid expense    492
Other undisclosed current assets    (492) 
Total current assets:  0111
Noncurrent Assets
TOTAL ASSETS:  0111
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:11070616071
Interest and dividends payable6     
Other undisclosed accounts payable and accrued liabilities(5)1070616071
Due to related parties35113158254
Other undisclosed current liabilities6  2511503
Total current liabilities:4221100121596578
Noncurrent Liabilities
Long-term debt and lease obligation101     
Long-term debt, excluding current maturities101     
Total noncurrent liabilities:101     
Total liabilities:14321100121596578
Stockholders' equity
Stockholders' equity attributable to parent, including:(143)(21)(100)(121)(595)(577)
Common stock6660223223
Additional paid in capital9,3669,3669,2448,5938,3558,349
Accumulated deficit(9,515)(9,392)(9,350)(8,715) (554)
Other undisclosed stockholders' equity attributable to parent    (9,173)(8,595)
Total stockholders' equity:(143)(21)(100)(121)(595)(577)
TOTAL LIABILITIES AND EQUITY:  0111

Income statement (P&L) ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
12/31/2011
Revenues   458  
Cost of revenue
(Cost of Goods and Services Sold)
  (6)(6)(6)(6)
Gross profit:  (6)452(6)(6)
Operating expenses(115)(0)(2)(31)(0)(16)
Operating income (loss):(115)(0)(8)421(6)(22)
Interest and debt expense(7) (605)   
Income (loss) before gain (loss) on sale of properties:(123)(0)(613)421(6)(22)
Other undisclosed net income (loss) (41)(22)37(18)(532)
Net income (loss) available to common stockholders, diluted:(123)(42)(635)458(24)(554)

Comprehensive Income ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
12/31/2011
Net income (loss):(123)(42)(635)458(24)(554)
Other comprehensive income (loss)  (635)458  
Comprehensive income (loss), net of tax, attributable to parent:(123)(42)(1,271)916(24)(554)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: